Efficacy and Safety of Direct Oral Anticoagulants Versus Standard Anticoagulation for Thromboprophylaxis in Nephrotic Syndrome: A Systematic Review and Meta-Analysis
Clinical and Applied Thrombosis/Hemostasis
Published online on April 08, 2026
Abstract
Clinical and Applied Thrombosis/Hemostasis, Volume 32, January-December 2026.
Prophylactic anticoagulation (PAC) is used to reduce the risk of thrombosis in patients with nephrotic syndrome (NS), yet the optimal agent remains uncertain. This systematic review and meta-analysis compare the efficacy and safety of direct oral ...
Prophylactic anticoagulation (PAC) is used to reduce the risk of thrombosis in patients with nephrotic syndrome (NS), yet the optimal agent remains uncertain. This systematic review and meta-analysis compare the efficacy and safety of direct oral ...